Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual Modulators
Open Access
- 25 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 9, 841190
Abstract
Both metabotropic (CBRs) and ionotropic cannabinoid receptors (ICRs) have implications in a range of neurological disorders. The metabotropic canonical CBRs CB1 and CB2 are highly implicated in these pathological events. However, selective targeting at CB2 versus CB1 offers optimized pharmacology due to the absence of psychoactive outcomes. The ICR transient receptor potential vanilloid type 1 (TRPV1) has also been reported to play a role in CNS disorders. Thus, activation of both targets, CB2 and TRPV1, offers a promising polypharmacological strategy for the treatment of neurological events including analgesia and neuroprotection. This brief research report aims to identify chemotypes with a potential dual CB2/TRPV1 profile. For this purpose, we have rationalized key structural features for activation and performed virtual screening at both targets using curated chemical libraries.Keywords
Funding Information
- Ministerio de Ciencia y Tecnología
- Consejo Superior de Investigaciones Científicas
- National Institute on Drug Abuse
- Ministerio de Ciencia e Innovación
This publication has 114 references indexed in Scilit:
- Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymesBritish Journal of Pharmacology, 2010
- TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrusNature Neuroscience, 2010
- TRPV1 channels control synaptic plasticity in the developing superior colliculusThe Journal of Physiology, 2009
- TRPV1 Channels Mediate Long-Term Depression at Synapses on Hippocampal InterneuronsNeuron, 2008
- Cannabinoid CB2receptors: a therapeutic target for the treatment of inflammatory and neuropathic painBritish Journal of Pharmacology, 2008
- Meta‐analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differencesBritish Journal of Pharmacology, 2007
- Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB1 and TRPV1 receptorsExperimental Neurology, 2007
- First “hybrid” ligands of vanilloid TRPV1 and cannabinoid CB2receptors and non‐polyunsaturated fatty acid‐derived CB2‐selective ligandsFEBS Letters, 2005
- Highly Selective CB1 Cannabinoid Receptor Ligands and Novel CB1/VR1 Vanilloid Receptor “Hybrid” LigandsBiochemical and Biophysical Research Communications, 2001
- Unsaturated Long-Chain N-Acyl-vanillyl-amides (N-AVAMs): Vanilloid Receptor Ligands That Inhibit Anandamide-Facilitated Transport and Bind to CB1 Cannabinoid ReceptorsBiochemical and Biophysical Research Communications, 1999